ADDERALL Abstracts of Scientific Publications

• Psychopharmacological interventions


• Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder


• An evaluation of stimulant medication on the reinforcing effects of play


• Cardiomyopathy due to ingestion of Adderall


• Hematologic changes associated with Adderall toxicity in a dog


• Non-medical psychostimulant use and sleep among undergraduate students


• Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder


• Differential effects of the D- and L-isomers of amphetamine on pharmacological MRI BOLD contrast in the rat


• Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release


• Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release)


• Adderall abuse in Texas, 1998-2004


• Salivary biomarker levels and diurnal variation: Associations with medications prescribed to control children's problem behavior


• Adderall (R) produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers


• Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder


• Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder - A preliminary tolerability and efficacy study


• Clinical assessment and treatment of ADHD in children


• Pharmacokinetic modeling and simulation of gastrointestinal transit effects on plasma concentrations of drugs from mixed immediate-release and enteric-coated pellet formulations


• Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder


• Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine


• The impact of the withdrawal of Adderall XR (long-acting mixed amphetamine salts) from the Canadian market on paediatric patients and their families


• A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD


• A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder


• Questions about Adderall XR


• Stimulant misuse in college for "pseudo-attention deficit disorder" during schizophrenia prodrome


• Deficits in diagnosis, treatment and continuity of care in African-American children and adolescents with ADHD


• Some effects of stimulant medication on response allocation: A double-blind analysis


• Less is more: Inpatient management of a child with complex pharmacotherapy


• Nonmedical use of prescription stimulants in the United States


• New doubts about the therapeutical use of psychostimulants in ADHD


• Medical use, illicit use and diversion of prescription stimulant medication


• Barr and Shire settle on Adderall


• Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder


• The Texas children's medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder


• Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: Update on new stimulant preparations, atomoxetine, and novel treatments


• College undergraduate Ritalin abusers in Southwestern California: Protective and risk factors


• Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study


• Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study


• Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration


• Critical involvement of dopaminergic neurotransmission in impulsive decision making


• Mixed amphetamine salts extended-release in the treatment of adult ADHD: A randomized, controlled trial


• Mechanism of action of agents used in attention-deficit/hyperactivity disorder


• Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder


• Treatment of adult ADHD and comorbid disorders


• Effects of long-term psychostimulant medication on growth of children with ADHD


• The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine


• Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD


• Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults


• US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada


• Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children


• Myocardial infarction in an adolescent taking Adderall


• Effects of stimulant medication on cognitive performance of children with ADHD


• Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core


• Adderall (R) produces differential dopamine overflow when compared to D-amphetamine in rat striatum


• Safety and efficacy of Adderall XR in adolescents with ADHD.


• Drug regulation - Inconclusive evidence puts Adderall back on the market


• Pharmacokinetics of mixed amphetamine salts extended release in adolescents with ADHD


• Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey


• Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD


• A dose-ranging study of a methylphenidate transdermal system in children with ADHD


• Update: attention deficit/hyperactivity disorder in the primary care office


• Efficacy and tolerability of long-term, open-label, mixed amphetamine salts extended realease in adolescents with ADHD


• Sociodemographic and economic comparisons of children prescribed longer-acting versus short-acting stimulant medications for attention deficit hyperactivity disorder


• Hypermotivational syndrome


• Illicit use of specific prescription stimulants: prevalence, motives, and routes of administration.


• Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD


• Safety, efficacy and extended duration of action of mixed amphetamine salts extendedrelease capsules for the treatment of ADHD


• Effectiveness and patterns of methamphetamine use in narcolepsy patients


• How informative are parent reports of attention-deficit/hyperactivity disorder symptoms for assessing outcome in clinical trials of long-acting treatments? A pooled analysis of parents' and teachers' reports


• Amphetamine excretion profile following multidose administration of mixed salt amphetamine preparation


• Could Fidgety Philipp be proof that ADHD is not a modern phenomenon?


• Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting


• Differential effects of d-amphetamine, Adderall((R)) and other amphetamine isomers on dopamine neurotransmission in the striatum and nucleus accumbens core


• Relationship between amphetamine ingestion and gingival enlargement


• Atomoxetine and TICS in ADHD


• Cost-effectiveness of Ritalin (TM) versus Adderall (TM) for first-line treatment of attention deficit/hyperactivity disorder (ADHD) in children


• Pharmacological management of attention-deficit hyperactivity disorder


• The effectiveness of stimulants of retard forms in children and adolescents with ADHD - a systematic overview


• A prospective study of stimulant response in preschool children: Insights from ROC analyses


• Pharmacological treatment of obesity in children with and without hyperinsulinemia


• SLI-381 (Adderall XR (R) 1) - A viewpoint


• Reply to comments by Gonzalez et al. on the CONCERTA, Adderall XR Food Evaluation (CAFE) study


• Stimulant therapy in fragile X syndrome


• Psychostimulant use in children with autistic spectrum disorder


• The impact of late-afternoon stimulant dosing for children with ADHD on parent and parent-child domains


• Amphetamine enantiomer excretion profile following administration of Adderall


• Updates on attention deficit hyperactivity disorder, child abuse and neglect, and sudden infant death syndrome


• The management of ADD/ADHD patients by community pediatricians: A community-wide survey


• A pharmacokinetic/pharmacodynamic study comparing a single morning dose of Adderall to twice-daily dosing in children with ADHD


• SLI-381 (Adderall XR (R) 1) - A viewpoint


• Attention deficit hyperactivity disorder: An update


• Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (ADDERALL XR), in children with ADHD


• Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall


• SLI-381 (Adderall XR (R))


• Amphetamine metabolism: Distinguishing illicit from prescription use


• Long-term safety and efficacy of once-daily Adderall (R) XR in adults with attention deficit hyperactivity disorder.


• Reassessing the efficacy of Adderall after prolonged treatment for attention deficit hyperactivity disorder


• Effect of food on early drug exposure from extended-release stimulants: Results from the Concerta (R), Adderall XR (TM) Food Evaluation (CAFE) Study


• A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder


• The use of psychostimulants in children with disruptive behavior disorders and developmental disabilities in a community setting


• Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study


• Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: A meta-analysis


• Comments on effect of food on early drug exposure from extended-release stimulants: Results from the CONCERTA((R)), Adderall XR (R) food evaluation study


• Influence of stimulants on electrodermal studies in fragile X syndrome


• The effects of delayed rewards, tokens, and stimulant medication on sportsmanlike behavior with ADHD-diagnosed children


• Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder


• 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy


• Adderall and seizures


• SLI381 (Adderall XR), a two-component, ExtendedRelease formulation of mixed amphetamine salts: Bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration


• Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): Efficacy rate and side effects


• Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): Efficacy rate and side effects


• Reassessing the efficacy of Adderall after prolonged treatment for attention-deficit hyperactivity disorder


• Adderall for obsessive-compulsive disorder


• Adderall and the FDA


• Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: A reanalysis using drug-placebo and drug-drug response curve methodology


• Short-term cardiovascular effects of methylphenidate and Adderall


• Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder


• Attention-deficit/hyperactivity disorder in adults - Beyond controversy


• Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder


• SLI381: a long-acting psychostimulant preparation for the treatment of attention-deficit hyperactivity disorder


• Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial


• Adderall, the atypicals, and weight gain


• Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD


• Stability of Adderall in extemporaneously compounded oral liquids


• Diagnosis and management of attention-deficit/hyperactivity disorder in children


• Pharmacotherapies for attention-deficit/hyperactivity disorder: Expected-cost analysis


• Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder


• Long-term behavioral response to Adderall in children and adolescents with ADHD


• Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder


• Dose response curves across ADHD subtypes: Differential effects between Adderall and methylphenidate


• A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder


• Stimulant drugs


• Management of stimulant medications in children with attention-deficit/hyperactivity disorder


• Safety and efficacy of Adderall in children newly diagnosed with attention deficit hyperactivity disorder (ADHD)


• Stimulant medication for the child with attention-deficit/hyperactivity disorder


• Assessment of Adderall (R) in ADHD


• Effectiveness of psychostimulant therapy on sleep disturbances in adults with attention deficit hyperactivity disorder (ADHD)


• Atrioventricular nodal re-entrant tachycardia associated with stimulant treatment


• Differential effectiveness of methylphenidate and Adderall (R) in school-age youths with attention deficit hyperactivity disorder


• A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder


• A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder


• Comparing Adderall and methylphenidate in attention deficit hyperactivity disorder


• Effectiveness and tolerability of Adderall in adults with attention deficit hyperactivity disorder


• Efficacy and side effects profile of Adderall in newly diagnosed children with attention deficit disorder: Preliminary results


• Psychopharmacology of ADHD: Children and adolescents


• The use of psychostimulants in the pediatric patient


• Objective and subjective measures of the pharmacodynamic effects of Adderall (R) in the treatment of children with ADHD in a controlled laboratory classroom setting


• Analog classroom assessment of Adderall (R) in children with ADHD


• Evaluation of individual subjects in the analog classroom setting: II. Effects of dose of amphetamine (Adderall (R))


• Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder


• Adderall in children with ADHD: Time-response and dose-response effects


• Severe weight loss induced by Adderall(R) in a child with ADHD

ADHD & ADD Information Centre

Attention Deficit Hyperactivity Disorder